LitCovid-sample-Glycan  

Documents (8) JSON TSV

source DB source ID text size updated at # proj. # Ann. updated_at
PMC 7199903 Site-specific glycan analysis of the SARS-CoV-2 spike SARS-CoV-2 spike protein, elaborated Vaccine 17.9 KB 2020-09-27 39 83 2021-01-19
PMC 7205724 Towards treatment planning of COVID-19: Rationale and hypothesis for the use of multiple immunosuppr 29.5 KB 2020-12-29 40 90 2021-01-19
PMC 7228307 Harnessing the immune system via FcγR function in immune therapy: a pathway to next‐gen mAbs FcγR an 60.9 KB 2020-09-27 37 2 2021-01-19
PMC 7253482 Vulnerabilities in coronavirus glycan shields despite extensive glycosylation Abstract Severe acute 37 KB 2020-09-27 37 51 2021-01-19
PMC 7361216 A sugar‐coated strategy to treat a rare neurologic disease provides a blueprint for a decoy glycan t 9.26 KB 2020-11-19 36 3 2021-01-19
PMC 7441788 Advances in the use of chloroquine and hydroxychloroquine for the treatment of COVID-19 J. SUN ET AL 42.1 KB 2020-09-27 37 1 2021-01-19
PMC 7443692 Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 Receptor Abstract The S 72.3 KB 2020-12-29 22 2,948 2021-01-19
PMC 7556165 ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives Abstract Angiotensin-converting 77 KB 2020-12-29 28 35 2021-01-19